Assyro AI

Orange Book product · Brand (NDA)

XIFYRM

MELOXICAM

Brand (NDA)NDA 218395RX AZURITY

At a glance

Jun 05, 2025

Approved

Brand (NDA)

Application

Not listed

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jun 05, 2025

    1 yr 1 mo ago

  2. Today

  3. Patent 12263176 expires

    Listed drug product patent expiration.

    Jul 31, 2041

    in 15 yr 4 mo

Pharmaceutical detail

Active ingredient

MELOXICAM

Strength

30MG/ML (30MG/ML)

Dosage form

SOLUTION

Route

INTRAVENOUS

TE code

Not listed

Application

NDA 218395

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
12263176Jul 31, 2041in 15 yr 4 mo
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.